Sign Up to like & get
recommendations!
1
Published in 2020 at "Antiviral Research"
DOI: 10.1016/j.antiviral.2020.104906
Abstract: Abstract Baloxavir, a new antiviral drug targeting cap-dependent endonuclease activity of polymerase acidic (PA) protein of influenza viruses, is now approved in multiple countries. Several substitutions at isoleucine 38 in PA protein (e.g., PA-I38T) have…
read more here.
Keywords:
influenza viruses;
baloxavir resistant;
next generation;
generation sequencing ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Influenza and Other Respiratory Viruses"
DOI: 10.1111/irv.13079
Abstract: In a post‐hoc analysis of the phase 3 BLOCKSTONE study (JapicCTI‐184180), we investigated household transmission of baloxavir‐resistant (PA/I38X) influenza viruses. Using baloxavir resistance rates from prior clinical trials and the rate of influenza transmission observed…
read more here.
Keywords:
blockstone study;
baloxavir resistant;
influenza;
transmission ... See more keywords